Galliprant

962 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

962

Total Reports

195

Deaths Reported

2030.0%

Death Rate

Active Ingredients

Galliprant

Administration Routes

UnknownOralOphthalmic

Species Affected

Dog 962

Most Affected Breeds

Retriever - Labrador 179

Shepherd Dog - German 63

Retriever - Golden 61

Crossbred Canine/dog 44

Dog (unknown) 34

Siberian Husky 30

Terrier - Bull - American Pit 30

Chihuahua 28

Collie - Border 27

Boxer (German Boxer) 25

Most Reported Reactions

Death by euthanasia 150

Lethargy (see also Central nervous system depression in Neurological) 146

Diarrhoea 93

Vomiting 85

Lack of efficacy - NOS 77

Ataxia 77

Seizure NOS 74

Urinary incontinence 72

Limb weakness 66

Anorexia 64

Not eating 64

Lameness 57

Outcome Breakdown

Ongoing

561 (58.3%)

Euthanized

150 (15.6%)

Recovered/Normal

107 (11.1%)

Outcome Unknown

97 (10.1%)

Died

45 (4.7%)

Recovered with Sequela

2 (0.2%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.